$1.87
-0.03-1.58%
Dern. MÀJ: Nov 18, 10:41 AM

Atossa Therapeutics (ATOS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $-0.56 | $-0.80 | 30.0 % |
| Q2 | Aug 7, 2026 | $-0.95 | $-1.09 | 12.8 % |
| Q1 | May 8, 2026 | $-1.11 | $-1.22 | 9.02 % |
| Q4 | Mar 25, 2026 | $-0.03 | $-1.11 | 97.3 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.80 | $-1.09 | $-1.22 | $-1.11 |
| Actual | $-0.56 | $-0.95 | $-1.11 | $-0.03 |
| Surprise | +30.0% | +12.8% | +9.02% | +97.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.84 | $-0.80 | $-0.69 | $-0.72 |
| Revenue | ||||
| Consensus | — | — | — | — |